BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $63,819,340 | +14.2% | 592,126 | -2.3% | 0.01% | 0.0% |
Q4 2023 | $55,892,920 | +54.3% | 605,951 | +5.7% | 0.01% | +42.9% |
Q2 2023 | $36,225,355 | +43.6% | 573,186 | +2.2% | 0.01% | +16.7% |
Q1 2023 | $25,230,032 | -9.2% | 560,792 | -11.6% | 0.01% | -14.3% |
Q4 2022 | $27,777,511 | -46.7% | 634,045 | -19.8% | 0.01% | -50.0% |
Q3 2022 | $52,116,025 | +67.8% | 790,955 | +28.6% | 0.01% | +75.0% |
Q2 2022 | $31,058,650 | -40.6% | 614,901 | -24.9% | 0.01% | -27.3% |
Q1 2022 | $52,283,033 | -39.5% | 818,457 | +1.5% | 0.01% | -38.9% |
Q4 2021 | $86,351,000 | +13.9% | 806,188 | +9.4% | 0.02% | +5.9% |
Q3 2021 | $75,787,000 | +28.0% | 737,157 | +9.5% | 0.02% | +30.8% |
Q2 2021 | $59,195,000 | -14.2% | 672,973 | -5.2% | 0.01% | -18.8% |
Q1 2021 | $69,024,000 | -21.1% | 709,908 | -9.0% | 0.02% | -20.0% |
Q4 2020 | $87,507,000 | -3.6% | 780,264 | -20.3% | 0.02% | -16.7% |
Q3 2020 | $90,782,000 | +0.6% | 979,314 | -15.3% | 0.02% | -7.7% |
Q2 2020 | $90,220,000 | -1.7% | 1,156,671 | -26.3% | 0.03% | -21.2% |
Q1 2020 | $91,803,000 | +14.9% | 1,569,812 | +57.4% | 0.03% | +50.0% |
Q4 2019 | $79,919,000 | +48.6% | 997,612 | +36.2% | 0.02% | +37.5% |
Q3 2019 | $53,795,000 | -26.5% | 732,212 | -5.6% | 0.02% | -30.4% |
Q2 2019 | $73,157,000 | +2.0% | 775,544 | -13.4% | 0.02% | 0.0% |
Q1 2019 | $71,688,000 | +67.9% | 895,544 | +13.1% | 0.02% | +43.8% |
Q4 2018 | $42,705,000 | -30.9% | 792,151 | 0.0% | 0.02% | -20.0% |
Q3 2018 | $61,835,000 | +5.0% | 792,151 | -14.6% | 0.02% | 0.0% |
Q2 2018 | $58,867,000 | -20.9% | 927,333 | +14.2% | 0.02% | -25.9% |
Q1 2018 | $74,438,000 | +27.1% | 811,752 | +4.5% | 0.03% | +28.6% |
Q4 2017 | $58,574,000 | +81.3% | 776,734 | +67.5% | 0.02% | +75.0% |
Q3 2017 | $32,305,000 | +70.0% | 463,695 | +23.7% | 0.01% | +50.0% |
Q2 2017 | $19,001,000 | +2610.6% | 375,000 | +1400.0% | 0.01% | – |
Q4 2016 | $701,000 | +32.3% | 25,000 | +25.0% | 0.00% | – |
Q2 2015 | $530,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |